Both cancer and immune cells have extreme metabolism.

This makes metabolism a good drug target to alter the survival or function of these cells.

We aim to identify metabolic fluxes altered in immune or tumor cells, then use genetic and pharmacologic approaches to target these pathways to improve tumor clearance.

A key approach we use is infusing heavy non-radioactive metabolic tracers, and then performing mass spectrometry to track tissue and cell type metabolism.